These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12418391)

  • 1. [Antiphospholipid syndrome and multiple sclerosis: differential-diagnostic aspects].
    Spirin NN; Pizova NV; Stepanov IO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; Suppl():42-5. PubMed ID: 12418391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interface of multiple sclerosis and antiphospholipid antibodies.
    Chapman J
    Thromb Res; 2004; 114(5-6):477-81. PubMed ID: 15507281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hughes syndrome and multiple sclerosis.
    Uthman I; Noureldine MH; Berjawi A; Skaf M; Haydar AA; Merashli M; Hughes GR
    Lupus; 2015 Feb; 24(2):115-21. PubMed ID: 25326228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multiple sclerosis and antiphospholipid syndrome--difficulties in differential diagnostics].
    Członkowska A; Sliwińska A
    Pol Arch Med Wewn; 2007; 117 Suppl():28-32. PubMed ID: 18778016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence of misdiagnosis in patients with multiple sclerosis and repeated positive anticardiolipin antibody testing based on magnetic resonance imaging and long term follow-up.
    Liedorp M; Sanchez E; van Hoogstraten IM; von Blomberg BM; Barkhof F; Polman CH; Killestein J
    J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1146-8. PubMed ID: 17878195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature.
    Cuadrado MJ; Khamashta MA; Ballesteros A; Godfrey T; Simon MJ; Hughes GR
    Medicine (Baltimore); 2000 Jan; 79(1):57-68. PubMed ID: 10670410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated anti-β2-glycoprotein I antibodies in neurology: a frontier syndrome between multiple sclerosis and antiphospholipid syndrome?
    Renaud M; Aupy J; Uring-Lambert B; Chanson JB; Collongues N; Blanc F; De Sèze J
    Eur J Neurol; 2014 Jun; 21(6):901-6. PubMed ID: 24698178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?
    Ferreira S; D'Cruz DP; Hughes GR
    Rheumatology (Oxford); 2005 Apr; 44(4):434-42. PubMed ID: 15644391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evoked potential studies in the antiphospholipid syndrome: differential diagnosis from multiple sclerosis.
    Paran D; Chapman J; Korczyn AD; Elkayam O; Hilkevich O; Groozman GB; Levartovsky D; Litinsky I; Caspi D; Segev Y; Drory VE
    Ann Rheum Dis; 2006 Apr; 65(4):525-8. PubMed ID: 16107510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid syndrome: critical analysis of the diagnostic path.
    Pengo V; Banzato A; Bison E; Denas G; Padayattil Jose S; Ruffatti A
    Lupus; 2010 Apr; 19(4):428-31. PubMed ID: 20353982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS?
    IJdo JW; Conti-Kelly AM; Greco P; Abedi M; Amos M; Provenzale JM; Greco TP
    Lupus; 1999; 8(2):109-15. PubMed ID: 10192504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of antiphospholipid antibody measured by EliA anticardiolipin antibodies and anti-β2Glycoprotein I antibodies in antiphospholipid syndrome].
    Fujieda Y; Shida H; Oku K; Bohgaki T; Amengual O; Horita T; Yasuda S; Atsumi T
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(5):430-6. PubMed ID: 25744643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome.
    Djokovic A; Stojanovich L; Kontic M; Stanisavljevic N; Radovanovic S; Marisavljevic D
    Isr Med Assoc J; 2014 Mar; 16(3):162-7. PubMed ID: 24761704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
    Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L
    Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphosphatidylserine antibodies as diagnostic indicators of antiphospholipid syndrome.
    Khogeer H; Alfattani A; Al Kaff M; Al Shehri T; Khojah O; Owaidah T
    Lupus; 2015 Feb; 24(2):186-90. PubMed ID: 25253571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of anticardiolipin antibodies in patient cohorts with distinct clinical manifestations of the antiphospholipid syndrome.
    Damoiseaux J; Peeters L; Hupperts R; Boreas A; ten Cate H; Tervaert JW
    Ann N Y Acad Sci; 2009 Sep; 1173():146-51. PubMed ID: 19758143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticardiolipin, other antiphospholipid antibody tests and diagnosis of the antiphospholipid syndrome.
    Smikle M; Wharfe G; Fletcher H; Reid M; Roye-Green K; Fredrick J; Pierangeli S
    Hum Antibodies; 2003; 12(3):63-6. PubMed ID: 14646034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.